KR890015746A - 메게스트롤 아세테이트로 aids 악액질을 치료하는 방법 - Google Patents

메게스트롤 아세테이트로 aids 악액질을 치료하는 방법 Download PDF

Info

Publication number
KR890015746A
KR890015746A KR1019890004726A KR890004726A KR890015746A KR 890015746 A KR890015746 A KR 890015746A KR 1019890004726 A KR1019890004726 A KR 1019890004726A KR 890004726 A KR890004726 A KR 890004726A KR 890015746 A KR890015746 A KR 890015746A
Authority
KR
South Korea
Prior art keywords
megestrol acetate
treat aids
aids cachexia
cachexia
administered
Prior art date
Application number
KR1019890004726A
Other languages
English (en)
Inventor
에이.마키슨 브리안
Original Assignee
원본미기재
브리스톨 마이어즈 컴페니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 브리스톨 마이어즈 컴페니 filed Critical 원본미기재
Publication of KR890015746A publication Critical patent/KR890015746A/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

내용 없음

Description

메게스트롤 아세테이트로 AIDS 악액질을 치료하는 방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 악액질을 지연 및/또는 감소시키기에 충분히 유효한 양의 메게스트롤 아세테이트를 병에 걸린 환자(인체)에게 투여하는 것을 포함하는 후천성면역결핍증과 연관된 악액질을 지연 및/또는 감소시키는 방법.
  2. 제 1 항에 있어서, 메게스트롤 아세테이트를 경구투여형태로 투여하는 방법.
  3. 제 2 항에 있어서, 투여량이 약 40 내지 1600mg/일 인 방법.
  4. 제 3 항에 있어서, 메게스트롤 아세테이트를 분할 투여양으로 투여하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890004726A 1988-04-12 1989-04-11 메게스트롤 아세테이트로 aids 악액질을 치료하는 방법 KR890015746A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18040788A 1988-04-12 1988-04-12
US180407 1988-04-12

Publications (1)

Publication Number Publication Date
KR890015746A true KR890015746A (ko) 1989-11-25

Family

ID=22660343

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890004726A KR890015746A (ko) 1988-04-12 1989-04-11 메게스트롤 아세테이트로 aids 악액질을 치료하는 방법

Country Status (4)

Country Link
EP (1) EP0338404A1 (ko)
JP (1) JPH0222227A (ko)
KR (1) KR890015746A (ko)
HU (1) HUT50044A (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3114198B2 (ja) * 1990-11-06 2000-12-04 ソニー株式会社 電子機器
US7101576B2 (en) * 2002-04-12 2006-09-05 Elan Pharma International Limited Nanoparticulate megestrol formulations
US9101540B2 (en) 2002-04-12 2015-08-11 Alkermes Pharma Ireland Limited Nanoparticulate megestrol formulations
MX2008007790A (es) 2005-12-22 2009-03-04 Anaborex Inc Composiciones y metodos para la prevencion y tratamiento de caquexia.
WO2014100418A2 (en) * 2012-12-20 2014-06-26 Kashiv Pharma, Llc Orally disintegrating tablet formulation for enhanced bioavailability

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0222385B1 (en) * 1985-11-13 1993-02-03 Research Development Corporation of Japan Sex hormones for the treatment of immunodeficiency diseases

Also Published As

Publication number Publication date
EP0338404A1 (en) 1989-10-25
JPH0222227A (ja) 1990-01-25
HUT50044A (en) 1989-12-28

Similar Documents

Publication Publication Date Title
KR920700649A (ko) 월경전기 증후군을 치료하는 방법
ES2040232T3 (es) Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina.
ATE165000T1 (de) Dosierungsform zur verzoegerten wirkstofffreisetzung
KR920702216A (ko) 아세틸 d-카르니틴의 녹내장 치료에의 용도
SE8803486L (sv) Dosform foer behandling av kardiovaskulaera sjukdomar
KR880002515A (ko) 흡수 및 작용이 빠른 설린다크 또는 나트륨 설린다크와 염기의 혼합물
FI922325A (fi) Oral sammansaettning foer botning av inflammatoriska tarmkanalsjukdomar.
AU681452B2 (en) Pernasal composition and pernasal preparation containing thesame
YU49026B (sh) UPOTREBA 17 Гџ -(N-TERC-BUTILKARBAMOIL)-4-AZA-5-ALFA-ANDROST-1-3-ON ZA PROIZVODNJU LEKA ZA TRETIRANJE ANDROGENE ALOPECIJE
KR910004187A (ko) 세트랄린을 사용한 조기사정의 치료방법
KR940018089A (ko) 내부조직의 방사선 손상에 대한 예방 및 처치방법
KR910019618A (ko) 발기부전증 치료용 제약 조성물
KR900004338A (ko) 5-(4-클로로페닐)-2,4- 디메틸-3h-1,2,4- 트리아졸-3-티온을 이용한 혈소판증가증의 치료방법
KR900007424A (ko) 세포보호성 약제로서의 n-아세틸글루코사민의 사용방법 및 그 조성물
KR890015746A (ko) 메게스트롤 아세테이트로 aids 악액질을 치료하는 방법
IE44598L (en) Coccidiocidal compositions
KR900005974A (ko) 남성의 성기능 장애 치료제
KR910009267A (ko) 우울증의 치료방법
JPS6483020A (en) Medicinal composition for preventing or treating aids
KR880002527A (ko) 신경변질 치료용 안 조성물
KR890007728A (ko) 진통제 제조방법
KR870010871A (ko) 재조합 인체 알파 인터페론에 의한 기저세포 암종의 병소내적 치료방법
KR900017599A (ko) 종양 치료용 약학 조성물
KR920011502A (ko) 인체 신경계의 통증을 치료할 수 있는 부자이중탕(附子理中湯)의 개량된 한방치료제 물질
KR870005642A (ko) 디플루니살과 트로메타민의 혼합물

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid